Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Expert Consensus on Nutrition Standards for Intensive Care Units in Resource Limited Settings

14 novembre 2026 aggiornato da: Vijay Sundarsingh, RESQ Nutri ICU group

International Consensus on Nutritional Practices in Resource-Limited Intensive Care Units: The RES-Q Nutri ICU (REsource-limited Standards & Quality for Nutrition in the ICU) Modified Delphi Consensus Study

The goal of this observational study is to develop practical, expert-agreed standards for nutrition care of critically ill adults in intensive care units (ICUs) in resource-limited settings. The main question it aims to answer is:

Which nutrition practices do international ICU experts agree are essential and achievable for critically ill patients in hospitals with limited resources?

Participants will be ICU doctors, dietitians and nurses with experience of nutrition care in resource-limited settings. They will rate a set of statements across five areas of ICU nutrition in anonymous online survey rounds. After each round they will see a summary of the group's responses and may revise their ratings. A statement reaches agreement when at least 80% of experts agree with it, and rounds will continue until responses stabilise. ICU survivors and family members will also review a plain-language version of the statements, and their feedback will be shared with the expert panel.

Panoramica dello studio

Stato

Non ancora reclutamento

Descrizione dettagliata

Background: International ICU nutrition guidelines come almost entirely from trials in high-income settings. Lower-middle-income countries contributed less than 1% of patients and low-income countries none. ICUs that lack dietitians, feeding pumps, indirect calorimetry, post-pyloric access, specialised formulas or laboratory monitoring have no agreed minimum standard. This includes ICUs in low- and middle-income countries, remote or public facilities anywhere, and ICUs during surges. "Resource-limited" here is defined by what resources are available, not by World Bank income group.

Design: This is an international, web-based modified Delphi study reported according to ACCORD. A multidisciplinary Steering Committee drafts and refines the statements and analyses responses but does not vote. An independent Delphi methodologist oversees the process to limit bias. Panellists are recruited by purposive sampling through professional networks and societies, aiming for diversity in profession, geography, sex and resource setting.

Statement development: Round 1 statements come from a systematic search of PubMed, Embase, Scopus, Web of Science, Google Scholar and ESPEN, ASPEN and ESICM guidelines, covering adult literature in English from 2015 to 2026. Two reviewers screen in Rayyan and report selection in a PRISMA diagram. Statements are grouped into five domains: screening and assessment; timing, route and delivery; monitoring and metabolic control; micronutrients and special situations; and team, documentation and quality improvement. An evidence summary goes out with Round 1.

Delphi process: Panellists will rate statements on a 9-point scale, give free-text comments and describe the resource limitations in their practice. In later rounds they receive their own previous rating, the group median and IQR, percentage agreement and anonymised comments. A statement is revised when at least 10% of respondents (at least four) raise the same issue, and revisions that change its meaning are re-rated. Rounds continue until responses are stable, and the panel then approves the final set.

Patient involvement: Five to ten ICU survivors or patient representatives take part in single interviews in their preferred language and rate the value of the Round 1 statements. Their views are fed back to the panel but do not count towards consensus.

Analysis: Consensus to include is at least 80% of ratings at 7-9, and consensus to exclude is at least 80% at 1-3. Stability is tested with the Wilcoxon signed-rank test between consecutive rounds. If attrition exceeds 20%, a sensitivity analysis is run. Exploratory comparisons are made by profession and by income setting.

Ethics: Approved by the Institutional Ethics Committee, Father Muller Medical College (FMIEC/CCM/495/2026), with electronic consent from panellists.

Tipo di studio

Osservativo

Iscrizione (Stimato)

50

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

Luoghi di studio

    • Karnataka
      • Mangalore, Karnataka, India, 575002
        • Father Muller Medical College
        • Contatto:

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

18 anni e precedenti (Adulto, Adulto più anziano)

Accetta volontari sani

N/A

Sessi ammissibili allo studio

Tutto

Metodo di campionamento

Campione non probabilistico

Popolazione di studio

The study population is an international, multidisciplinary panel of about 40 to 50 professionals with expertise in adult critical care nutrition practice, research, education or guideline development. It includes intensivists, ICU dietitians, critical care nurses, clinical pharmacists, nutrition researchers and allied professionals involved in ICU nutrition. At least 60% of the panel will be from low- and middle-income countries or will have current experience of working in resource-limited ICUs, and at least one-third will be non-physicians. In addition, 5 to 10 adult ICU survivors or patient-care representatives, mainly from resource-limited settings, will take part in patient and public involvement interviews.

Descrizione

Inclusion Criteria:

  • Panellists will be eligible if they meet all of the following criteria:

    1. Professional background: Adult ICU clinicians or researchers involved in critical care nutrition practice, research, education, or guideline development, and belonging to one of the following professional groups: intensivists, ICU dietitians, critical care nurses, clinical pharmacists, nutrition researchers, or allied professionals involved in ICU nutrition.

    2. Relevant expertise: At least one of the following:

      1. At least one peer-reviewed publication related to critical care nutrition.
      2. A minimum of 10 years of relevant ICU or nutrition experience, with at least 50% of clinical time spent managing critically ill patients.
      3. Involvement in nutrition guideline or protocol development.
      4. A leadership or advocacy role in a critical care or nutrition society; or
      5. At least 5 years of direct experience working in resource-limited ICU settings.
    3. Willingness to participate: Willingness to participate in multiple Delphi rounds.

    4. Professional diversity: At least one-third of the final panel will comprise non-physicians.

Exclusion Criteria:

  • 1. Failure to provide implied consent through survey participation. 2. Inability to comprehend or independently vote on statements written in English. (To support non-native English speakers, all Delphi statements will be written in clear, unambiguous English.) 3. Incomplete Round 1 response with no rating data.

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Modelli osservazionali: OTHER
  • Prospettive temporali: PROSPECTIVE

Coorti e interventi

Gruppo / Coorte
Expert Delphi Panel

International multidisciplinary panel of approximately 40 to 50 experts in adult critical care nutrition, including intensivists, ICU dietitians, critical care nurses, clinical pharmacists and nutrition researchers.At least 60% will be from low- and middle-income countries or resource-limited ICUs, and at least one-third will be non-physicians. Panellists will rate draft statements on minimum nutrition standards over iterative anonymous online rounds until consensus and stability are reached.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
To establish consensus-based minimum standards for assessment, initiation, delivery, and monitoring of nutritional therapy in resource-limited ICUs.
Lasso di tempo: Through study completion, an average of 18 months

Number and proportion of Delphi statements reaching consensus to include (at least 80% of panellists rating 7 to 9 on a 9-point Likert scale) or consensus to exclude (at least 80% rating 1 to 3), with response stability between consecutive rounds (no significant variation on the Wilcoxon signed-rank or Kruskal-Wallis test, p of 0.05 or more). For each statement, the median, interquartile range and percentage agreement will be reported.

Through study completion, an average of 18 months

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
To identify pragmatic adaptations of existing international ICU nutrition guidelines for resource-limited settings.
Lasso di tempo: Through study completion, an average of 18 months

Number and proportion of statements describing adaptations of ESPEN, ASPEN or ESICM recommendations that reach consensus to include (at least 80% rating 7 to 9) with response stability.

Through study completion, an average of 18 months
To identify essential (minimum) nutritional practices for critically ill patients in ICUs
Lasso di tempo: Through study completion, an average of 18 months

Number and proportion of statements rated "essential" (7 to 9) by at least 80% of panellists with response stability, reported for each of the five domains.

Through study completion, an average of 18 months
To identify research priorities in ICU nutrition for resource-limited settings.
Lasso di tempo: Through study completion, an average of 18 months

Research priorities identified from statements reaching no consensus after repeated rating, and from themes in panellists' free-text comments, analysed thematically.

Through study completion, an average of 18 months

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Investigatori

  • Investigatore principale: Vijay Sundarsingh, MD,DM, Father Muller Medical College
  • Investigatore principale: Soumaya Touzani, MD, PhD, Hassan II University Hospital
  • Investigatore principale: Prashant Nasa, MD,FNB, University Hospital Plymouth NHS Trust, Plymouth, UK

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Stimato)

1 gennaio 2027

Completamento primario (Stimato)

31 dicembre 2027

Completamento dello studio (Stimato)

30 giugno 2028

Date di iscrizione allo studio

Primo inviato

9 novembre 2026

Primo inviato che soddisfa i criteri di controllo qualità

14 novembre 2026

Primo Inserito (Effettivo)

19 novembre 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

19 novembre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

14 novembre 2026

Ultimo verificato

1 novembre 2026

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • FMIEC/CCM/495/2026

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Descrizione del piano IPD

Individual participant data will not be shared. Participants consented to their responses being reported only in aggregate, and the small expert panel carries a risk of re-identification. Aggregate results for each statement will be published in the final manuscript.

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi